
|Articles|June 1, 2001
Tamoxifen for male CAD
News brief.
Advertisement
Research Headlines
Tamoxifen for male CAD
By Jeanne Sabatie, Production Editor
Men with coronary artery disease may benefit from tamoxifen, a drug used to treat breast cancer. A study in the March 20 issue of Circulation reported improved vessel dilationthe ability of arteries to expand with increased blood flowin subjects taking tamoxifen along with conventional medications.
Jeanne Sabatie. Tamoxifen for male CAD.
Business and Health
2001;6:8.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Nonfactor agents for hemophilia prophylaxis: A Q&A with Steven Pipe, M.D.
2
What Health Plans Should Ask For in Their PBM Contracts If They Want Transparency | AMCP Nexus 2025
3
Automated Prior Authorization Speeds Approval of GLP-1 Therapies | AMCP Nexus 2025
4
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations
5

















































